|
1
|
American Diabetes Association. 2.
Classification and diagnosis of diabetes: Standards of medical care
in diabetes-2018. Diabetes Care. 41 (Suppl 1):S13–S27.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Jiwani A, Marseille E, Lohse N, Damm P,
Hod M and Kahn JG: Gestational diabetes mellitus: Results from a
survey of country prevalence and practices. J Matern Fetal Neonatal
Med. 25:600–610. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Li Z, Cheng Y, Wang D, Chen H, Chen H,
Ming WK and Wang Z: Incidence rate of type 2 diabetes mellitus
after gestational diabetes mellitus: A systematic review and
meta-analysis of 170,139 women. J Diabetes Res.
2020(3076463)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Catalano PM and Ehrenberg HM: The short-
and long-term implications of maternal obesity on the mother and
her offspring. BJOG. 113:1126–1133. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ehrenberg HM, Mercer BM and Catalano PM:
The influence of obesity and diabetes on the prevalence of
macrosomia. Am J Obstet Gynecol. 191:964–968. 2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li RH and Wozney JM: Delivering on the
promise of bone morphogenetic proteins. Trends Biotechnol.
19:255–265. 2001.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hogan BL: Bone morphogenetic proteins in
development. Curr Opin Genet Dev. 6:432–438. 1996.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Miyazono K, Maeda S and Imamura T: BMP
receptor signaling: Transcriptional targets, regulation of signals,
and signaling cross-talk. Cytokine Growth Factor Rev. 16:251–263.
2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cao S, Reece EA, Shen WB and Yang P:
Restoring BMP4 expression in vascular endothelial progenitors
ameliorates maternal diabetes-induced apoptosis and neural tube
defects. Cell Death Dis. 11(859)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bostrom KI, Jumabay M, Matveyenko A,
Nicholas SB and Yao Y: Activation of vascular bone morphogenetic
protein signaling in diabetes mellitus. Circ Res. 108:446–457.
2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hu J, Liu J, Kwok MW, Wong RH, Huang Y and
Wan S: Bone morphogenic protein-4 contributes to venous endothelial
dysfunction in patients with diabetes undergoing coronary
revascularization. Ann Thorac Surg. 95:1331–1339. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sorescu GP, Song H, Tressel SL, Hwang J,
Dikalov S, Smith DA, Boyd NL, Platt MO, Lassègue B, Griendling KK
and Jo H: Bone morphogenic protein 4 produced in endothelial cells
by oscillatory shear stress induces monocyte adhesion by
stimulating reactive oxygen species production from a nox1-based
NADPH oxidase. Circ Res. 95:773–779. 2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sanchez-de-Diego C, Valer JA,
Pimenta-Lopes C, Rosa JL and Ventura F: Interplay between BMPs and
reactive oxygen species in cell signaling and pathology.
Biomolecules. 9(534)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Miriyala S, Gongora Nieto MC, Mingone C,
Smith D, Dikalov S, Harrison DG and Jo H: Bone morphogenic
protein-4 induces hypertension in mice: Role of noggin, vascular
NADPH oxidases, and impaired vasorelaxation. Circulation.
113:2818–2825. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yang X, Long L, Southwood M,
Rudarakanchana N, Upton PD, Jeffery TK, Atkinson C, Chen H,
Trembath RC and Morrell NW: Dysfunctional Smad signaling
contributes to abnormal smooth muscle cell proliferation in
familial pulmonary arterial hypertension. Circ Res. 96:1053–1063.
2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wong WT, Tian XY, Chen Y, Leung FP, Liu L,
Lee HK, Ng CF, Xu A, Yao X, Vanhoutte PM, et al: Bone morphogenic
protein-4 impairs endothelial function through oxidative
stress-dependent cyclooxygenase-2 upregulation: Implications on
hypertension. Circ Res. 107:984–991. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Luo JY, Zhang Y, Wang L and Huang Y:
Regulators and effectors of bone morphogenetic protein signalling
in the cardiovascular system. J Physiol. 593:2995–3011.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Youn JY, Zhou J and Cai H: Bone
morphogenic protein 4 mediates NOX1-dependent eNOS uncoupling,
endothelial dysfunction, and COX2 induction in type 2 diabetes
mellitus. Mol Endocrinol. 29:1123–1133. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Altman D, Carroli G, Duley L, Farrell B,
Moodley J, Neilson J and Smith D: Magpie Trial Collaboration Group.
Do women with pre-eclampsia, and their babies, benefit from
magnesium sulphate? The magpie trial: A randomised
placebo-controlled trial. Lancet. 359:1877–1890. 2002.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Knuist M, Bonsel GJ, Zondervan HA and
Treffers PE: Intensification of fetal and maternal surveillance in
pregnant women with hypertensive disorders. Int J Gynaecol Obstet.
61:127–133. 1998.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hauth JC, Ewell MG, Levine RJ, Esterlitz
JR, Sibai B, Curet LB, Catalano PM and Morris CD: Pregnancy
outcomes in healthy nulliparas who developed hypertension. Calcium
for preeclampsia prevention study group. Obstet Gynecol. 95:24–28.
2000.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Schneider S, Freerksen N, Rohrig S, Hoeft
B and Maul H: Gestational diabetes and preeclampsia-similar risk
factor profiles? Early Hum Dev. 88:179–184. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Roberts JM and Lain KY: Recent Insights
into the pathogenesis of pre-eclampsia. Placenta. 23:359–372.
2002.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Conti E, Zezza L, Ralli E, Caserta D,
Musumeci MB, Moscarini M, Autore C and Volpe M: Growth factors in
preeclampsia: A vascular disease model. A failed vasodilation and
angiogenic challenge from pregnancy onwards? Cytokine Growth Factor
Rev. 24:411–425. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
de Resende Guimarães MFB, Brandão AHF, de
Lima Rezende CA, Cabral ACV, Brum AP, Leite HV and Capuruço CAB:
Assessment of endothelial function in pregnant women with
preeclampsia and gestational diabetes mellitus by flow-mediated
dilation of brachial artery. Arch Gynecol Obstet. 290:441–447.
2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Abdul Aziz SH, John CM, Mohamed Yusof NI,
Nordin M, Ramasamy R, Adam A and Fauzi FM: Animal model of
gestational diabetes mellitus with pathophysiological resemblance
to the human condition induced by multiple factors (nutritional,
pharmacological, and stress) in rats. Biomed Res Int.
2016(9704607)2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mdaki KS, Larsen TD, Wachal AL,
Schimelpfenig MD, Weaver LJ, Dooyema SD, Louwagie EJ and Baack ML:
Maternal high-fat diet impairs cardiac function in offspring of
diabetic pregnancy through metabolic stress and mitochondrial
dysfunction. Am J Physiol Heart Circ Physiol. 310:H681–H692.
2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Gutierrez JC, Bahamonde J, Prater MR, Yefi
CP and Holladay SD: Production of a type 2 maternal diabetes rodent
model using the combination of high-fat diet and moderate dose of
streptozocin. Endocr Res. 35:59–70. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Vesentini G, Marini G, Piculo F, Damasceno
DC, Matheus SMM, Felisbino SL, Calderon IMP, Hijaz A, Barbosa AMP
and Rudge MVC: Morphological changes in rat rectus abdominis muscle
induced by diabetes and pregnancy. Braz J Med Biol Res.
51(e7035)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Suckow MA, Gobbett TA and Peterson RG:
Wound healing delay in the ZDSD rat. In Vivo. 31:55–60.
2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Domon A, Katayama K, Tochigi Y and Suzuki
H: Characterization of novel nonobese type 2 diabetes rat model
with enlarged kidneys. J Diabetes Res. 2019(8153140)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Laurino LF, Viroel FJM, Caetano E, Spim S,
Pickler TB, Rosa-Castro RM, Vasconcelos EA, Jozala AF, Hataka A,
Grotto D and Gerenutti M: Lentinus edodes exposure before and after
fetus implantation: Materno-fetal development in rats with
gestational diabetes mellitus. Nutrients. 11(2720)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Danda RS, Habiba NM, Rincon-Choles H,
Bhandari BK, Barnes JL, Abboud HE and Pergola PE: Kidney
involvement in a nongenetic rat model of type 2 diabetes. Kidney
Int. 68:2562–2571. 2005.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Catena C, Giacchetti G, Novello M, Colussi
G, Cavarape A and Sechi LA: Cellular mechanisms of insulin
resistance in rats with fructose-induced hypertension. Am J
Hypertens. 16:973–978. 2003.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Elmarakby AA and Imig JD: Obesity is the
major contributor to vascular dysfunction and inflammation in
high-fat diet hypertensive rats. Clin Sci (Lond). 118:291–301.
2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Singh VP, Le B, Khode R, Baker KM and
Kumar R: Intracellular angiotensin II production in diabetic rats
is correlated with cardiomyocyte apoptosis, oxidative stress, and
cardiac fibrosis. Diabetes. 57:3297–3306. 2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Feldman DL, Jin L, Xuan H, Contrepas A,
Zhou Y, Webb RL, Mueller DN, Feldt S, Cumin F, Maniara W, et al:
Effects of aliskiren on blood pressure, albuminuria, and (pro)renin
receptor expression in diabetic TG(mRen-2)27 rats. Hypertension.
52:130–136. 2008.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Imanishi T, Tsujioka H, Ikejima H, Kuroi
A, Takarada S, Kitabata H, Tanimoto T, Muragaki Y, Mochizuki S,
Goto M, et al: Renin inhibitor aliskiren improves impaired nitric
oxide bioavailability and protects against atherosclerotic changes.
Hypertension. 52:563–572. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Corvol P, Michaud A, Soubrier F and
Williams TA: Recent advances in knowledge of the structure and
function of the angiotensin I converting enzyme. J Hypertens Suppl.
13:S3–10. 1995.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wei L, Alhenc-Gelas F, Soubrier F, Michaud
A, Corvol P and Clauser E: Expression and characterization of
recombinant human angiotensin I-converting enzyme. Evidence for a
C-terminal transmembrane anchor and for a proteolytic processing of
the secreted recombinant and plasma enzymes. J Biol Chem.
266:5540–5546. 1991.PubMed/NCBI
|
|
41
|
Linz W, Gohlke P, Unger T and Scholkens
BA: Experimental evidence for effects of ramipril on cardiac and
vascular hypertrophy beyond blood pressure reduction. Arch Mal
Coeur Vaiss. 2:31–34. 1995.PubMed/NCBI
|
|
42
|
Csiszar A, Ahmad M, Smith KE, Labinskyy N,
Gao Q, Kaley G, Edwards JG, Wolin MS and Ungvari Z: Bone
morphogenetic protein-2 induces proinflammatory endothelial
phenotype. Am J Pathol. 168:629–638. 2006.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Csiszar A, Labinskyy N, Jo H, Ballabh P
and Ungvari Z: Differential proinflammatory and prooxidant effects
of bone morphogenetic protein-4 in coronary and pulmonary arterial
endothelial cells. Am J Physiol Heart Circ Physiol. 295:H569–H577.
2008.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Frank DB, Abtahi A, Yamaguchi DJ, Manning
S, Shyr Y, Pozzi A, Baldwin HS, Johnson JE and de Caestecker MP:
Bone morphogenetic protein 4 promotes pulmonary vascular remodeling
in hypoxic pulmonary hypertension. Circ Res. 97:496–504.
2005.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Yang J, Davies RJ, Southwood M, Long L,
Yang X, Sobolewski A, Upton PD, Trembath RC and Morrell NW:
Mutations in bone morphogenetic protein type II receptor cause
dysregulation of Id gene expression in pulmonary artery smooth
muscle cells: Implications for familial pulmonary arterial
hypertension. Circ Res. 102:1212–1221. 2008.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Koga M, Engberding N, Dikalova AE, Chang
KH, Seidel-Rogol B, Long JS, Lassègue B, Jo H and Griendling KK:
The bone morphogenic protein inhibitor, noggin, reduces glycemia
and vascular inflammation in db/db mice. Am J Physiol Heart Circ
Physiol. 305:H747–H755. 2013.PubMed/NCBI View Article : Google Scholar
|
